Serum Transthyretin as Prognostic Biomarker for Cardiovascular Events and Mortality: A Systematic Review and Meta-Analysis
{{output}}
Background: Serum transthyretin (TTR) levels, a key player in the occurrence of amyloidosis, have also emerged as a potential biomarker in cardiovascular (CV) disease and all-cause mortality. However, it is unclear whether TTR le... ...
